• No results found

Transdermal Patches formulation and evaluation

FORMULATION AND EVALUATION OF HERBAL TRANSDERMAL PATCHES

FORMULATION AND EVALUATION OF HERBAL TRANSDERMAL PATCHES

... in transdermal drug patches. Transdermal drug delivery system (TDDS) thus offers a better route of delivery, reported to have better patient ...

10

 FORMULATION AND EVALUATION OF AMLODIPINE TRANSDERMAL PATCHES USING ETHYL CELLULOSE

 FORMULATION AND EVALUATION OF AMLODIPINE TRANSDERMAL PATCHES USING ETHYL CELLULOSE

... application. Transdermal drug delivery provides a leading edge over injectables and oral route by increasing patient compliances and avoiding first pass metabolism ...

5

FORMULATION, CHARACTERIZATION AND IN VITRO EVALUATION OF DULOXETINE HYDROCHLORIDE TRANSDERMAL PATCHES

FORMULATION, CHARACTERIZATION AND IN VITRO EVALUATION OF DULOXETINE HYDROCHLORIDE TRANSDERMAL PATCHES

... T-10 transdermal patch was found to be 91% after 480 minutes physical measurement thickness was found to be 18mm, with folding endurance test of 190 times and content uniformity was found to be ...

27

Formulation and Evaluation of Transdermal Patches of Ketoprofin by Using Different Polymers

Formulation and Evaluation of Transdermal Patches of Ketoprofin by Using Different Polymers

... The purpose of this research work was to develop and evaluate matrix-type transdermal patches of Ketoprofen. Employing different ratios of hydrophilic and hydrophobic polymers by solvent evaporation ...

12

FORMULATION AND EVALUATION OF TRANSDERMAL PATCHES OF 18 Β GLYCYRRHETIC ACID

FORMULATION AND EVALUATION OF TRANSDERMAL PATCHES OF 18 Β GLYCYRRHETIC ACID

... Transdermal patches deliver drugs at a constant rate for 24 hours or longer. Norplant system releases progestin levonorgestel from silicon rubber tubular capsules for several years. The promise of zero ...

6

Formulation and Development of Transdermal Patches of Piroxicam

Formulation and Development of Transdermal Patches of Piroxicam

... developed formulation and development of transdermal patches of ...piroxicam. Transdermal patches increase the patient compliance over conventional dosage ...form. Transdermal ...

10

FORMULATION AND EVALUATION OF NICOTINE TRANSDERMAL PATCHES BY THE USING OF HYDROPHILIC AND HYDROPHOBIC POLYMERS

FORMULATION AND EVALUATION OF NICOTINE TRANSDERMAL PATCHES BY THE USING OF HYDROPHILIC AND HYDROPHOBIC POLYMERS

... prepared patches were evaluated by Compatibility study, Physical appearance, Thickness uniformity, Weight uniformity, Tensile strength, Folding endurance, Percentage Moisture content, Percentage Moisture uptake, ...

15

FORMULATION AND EVALUATION OF TRANSDERMAL PATCHES OF KETOPROFIN BY USING DIFFERENT POLYMERS

FORMULATION AND EVALUATION OF TRANSDERMAL PATCHES OF KETOPROFIN BY USING DIFFERENT POLYMERS

... CONCLUSION: The following conclusions were drawn from the results obtained. A suitable UV Spectroscopy method for the analysis of Fenoprofen was developed. Ketoprofen showed maximum absorption at wavelength 245nm in ...

9

FORMULATION AND IN VITRO EVALUATION OF TRANSDERMAL MATRIX PATCHES OF DOXOPHYLLINE

FORMULATION AND IN VITRO EVALUATION OF TRANSDERMAL MATRIX PATCHES OF DOXOPHYLLINE

... type transdermal patch with the varied proportion of hydrophilic hydroxy propyl methyl cellulose E-50 (HPMC E-50) and (poly vinyl pyrrolidone [PVP]) combination incorporating the drug doxofylline and to execute ...

6

Pharmaceutical Formulation and Biochemical Evaluation of Atorvastatin Transdermal Patches

Pharmaceutical Formulation and Biochemical Evaluation of Atorvastatin Transdermal Patches

... ATO- transdermal patches utilizing various polymers ...The patches were prepared by solvent evaporation ...biochemical evaluation of the best formulae was evaluated on hyperlipidemic-induced ...

8

Formulation and Evaluation of Matrix Type Transdermal Patches of Benazepril Hydrochloride.

Formulation and Evaluation of Matrix Type Transdermal Patches of Benazepril Hydrochloride.

... the transdermal patches are carried out using modified paddle over disc assembly (USP Apparatus 5) (Martin Siewert et al ...The transdermal patch of specified area is pasted over a small piece of ...

202

Formulation and Evaluation of Transdermal patches of Maloxicam using Solvent Casting Technique

Formulation and Evaluation of Transdermal patches of Maloxicam using Solvent Casting Technique

... delivery patches have been in the market for over a decade. Transdermal drug delivery system (TDDS) has been an increased interest in the drug administration via the skin for both local therapeutic effects ...

12

FORMULATION AND EVALUATION IN VITRO A MATRIX TYPE OF KETOTIFEN FUMARATE TRANSDERMAL PATCHES FOR ALLERGIC DISEASES

FORMULATION AND EVALUATION IN VITRO A MATRIX TYPE OF KETOTIFEN FUMARATE TRANSDERMAL PATCHES FOR ALLERGIC DISEASES

... Transdermal therapeutic system was specifically designed to obtain systemic blood levels and have been used in the United States since 1950s. The advantages are: Avoiding the chemically hostile gastrointestinal ...

7

Formulation characterization and in vitro evaluation of class 1c antiarrhythmic agent: propafenone into transdermal patches

Formulation characterization and in vitro evaluation of class 1c antiarrhythmic agent: propafenone into transdermal patches

... of transdermal patches of PROPAFENONE using polymers of HPMC-15 CPS, SODIUM ALGINATE and METHOCEL K ...100. Transdermal patches were prepared using HPMC-15cps from trials T-1 to t- 5, in which ...

10

FORMULATION AND EVALUATION OF CLOPIDOGREL BISULPHATE TRANSDERMAL PATCHES USING VEGETABLE OILS AS PERMEATION ENHANCER

FORMULATION AND EVALUATION OF CLOPIDOGREL BISULPHATE TRANSDERMAL PATCHES USING VEGETABLE OILS AS PERMEATION ENHANCER

... was formulation and evaluation of transdermal drug delivery system of Clopidogrel bisulphate using vegetable oils as permeation enhancer by using solvent evaporation technique for improvement of ...

10

FORMULATION DEVELOPMENT AND EVALUATION OF PHENYLEPHRINE HYDROCHLORIDE TRANSDERMAL PATCHES BY USING SOLVENT EVAPORATION METHOD

FORMULATION DEVELOPMENT AND EVALUATION OF PHENYLEPHRINE HYDROCHLORIDE TRANSDERMAL PATCHES BY USING SOLVENT EVAPORATION METHOD

... type transdermal therapeutic system containing a Phenylephrine hydrochloride with different ratios of HPMC K-100 and Eudragit L-100 by solvent evaporation ...formulated patches will evaluated for physical ...

6

TRANSDERMAL PATCHES:  PHYSIOCHEMICAL AND IN VITRO EVALUATION METHODS

TRANSDERMAL PATCHES: PHYSIOCHEMICAL AND IN VITRO EVALUATION METHODS

... . Skin or tissue is mounted sandwiched between the donor and the receptor compartment. Drug formulation is placed in the donor compartment. It is in contact with tissue on one side and the tissueis in contact with ...

11

89. Evaluation of nootropic activity and formulation of transdermal patches of cod liver oil

89. Evaluation of nootropic activity and formulation of transdermal patches of cod liver oil

... Transdermal patches control the delivery of drugs at controlled rates by employing an appropriate combination of hydrophilic and lipophilic ...the transdermal dosage form is user friendly, ...

9

“Formulation and Evaluation of Transdermal Patches of Cetrizine Dihydrochloride” by K.Nukaraju, T.Veerraju, K.Satyavathi, India.

“Formulation and Evaluation of Transdermal Patches of Cetrizine Dihydrochloride” by K.Nukaraju, T.Veerraju, K.Satyavathi, India.

... via transdermal route can bypass various disadvantages caused by oral administration and may maintain relatively consistent plasma drug level for long time therapy ...monolithic transdermal system of ...

5

FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF MATRIX TYPE TRANSDERMAL PATCHES OF ROSIGLITAZONE MALEATE

FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF MATRIX TYPE TRANSDERMAL PATCHES OF ROSIGLITAZONE MALEATE

... type transdermal patches of Rosiglitazone Maleate by using Ethylcellulose and Eudragit as polymers at different combinations to minimize adverse effects associated with oral ...administration. ...

9

Show all 10000 documents...

Related subjects